Francis Medical

Francis Medical

Private
Maple Grove, MinnesotaHealthcare & Life Scienceshttps://www.francismedical.com

Last Round

Series C

Jan 7, 2025

Total Funding Raised

$157M

Momentum Score

75 /100

Company Overview

Francis Medical is a healthcare company specializing in innovative cancer treatments that utilize water vapor technology to ablate cancerous tissue in the prostate, urinary bladder, and kidney while minimizing damage to surrounding structures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

water vapor ablationprostate cancer treatmentminimally invasive therapyablation technologythermal ablationurological cancerstransurethral procedureVanquish systemprostate cancer deviceFDA breakthrough devicemedical device salesclinical trialskidney cancerbladder cancer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Francis Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Francis Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CJan 7, 2025
Series BSep 15, 2021
StrategicSep 29, 2020
Series ADec 13, 2018

Key People

Founding team and executive leadership

Michael Hoey

Founder Director President CTO

Founding Team

Mike Kujak

President, CEO Director

Executive Team

Francis Medical Investors

Notable investors and investment history

InvestorRounds
Tonkawa Inc.Series C
Arboretum VenturesSeries B, Series C, Series A
Orlando Health VenturesSeries C
Boston Scientific CorporationSeries A
Coloplast A/SSeries C, Series B, Strategic
Solas BioVenturesSeries A, Series C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 25, 2026

    First commercial use of Vanquish procedure for prostate tissue ablation completed.

  • Jan 7, 2025

    $80M round closed.

Francis Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Francis Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Francis Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMaple Grove, Minnesota
Employee Range70
Year Founded2018
Last FundingJan 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.